Vimarsana
Biggest News Aggregation in the World

James Bonnar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from James Bonnar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In James Bonnar Today - Breaking & Trending Today

Wander down Memory Lane to see how Dunfermline used to be - Vimarsana News

Wander down Memory Lane to see how Dunfermline used to be

“Very few people owned their homes with the majority living in rented accommodation. Most houses consisted of two, three or four rooms, which…

Memory Lane: Looking back at Dunfermline shops of the past - Vimarsana News

Memory Lane: Looking back at Dunfermline shops of the past

The photographs in this week’s trip down West Fife’s Memory Lane look at some of the shops that once operated in the centre of Dunfermline.

In pictures: A look back at some of Dunfermline's long-lost shops - Vimarsana News

In pictures: A look back at some of Dunfermline's long-lost shops

IN THIS week’s trip down West Fife’s Memory Lane, we look at some of the shops that used to be in Dunfermline.

Nyrada announces to new cholesterol-lowering drug candidates - Vimarsana News

Nyrada announces to new cholesterol-lowering drug candidates

Date Time Nyrada announces to new cholesterol-lowering drug candidates Australian preclinical drug development company Nyrada (ASX:NYR) has provided an update on the progress of its small molecule cholesterol-lowering program. The company said a previous in vivo preclinical study showed NYX-PCSK9i reduced total cholesterol by 57 per cent without adverse side effects. It said it has now commenced a new in vivo efficacy study in the same specialised transgenic mouse model to evaluate NYX-PCSK9i in combination with a statin. Nyrada said the study aims to determine if NYX-PCSK9i enhances the effi...

Nyrada Inc (ASX:NYR) 57% Reduction in Total Cholesterol from Nyrada's NYX-PCSK9i In Vivo Study - Vimarsana News

Nyrada Inc (ASX:NYR) 57% Reduction in Total Cholesterol from Nyrada's NYX-PCSK9i In Vivo Study

Nyrada Inc (ASX:NYR) 57% Reduction in Total Cholesterol from Nyrada's NYX-PCSK9i In Vivo Study    57% Reduction in Total Cholesterol from Nyrada's NYX-PCSK9i In Vivo StudySydney, Dec 21, 2020 AEST (ABN Newswire) - Nyrada Inc ( ASX:NYR) is pleased to report encouraging efficacy results from its cholesterol-lowering drug program which is directed at developing an oral PCSK9 inhibitor treatment for hypercholesterolemia (high cholesterol). - Very encouraging preliminary in vivo efficacy results for Nyrada's oral PCSK9 inhibitor NYX-PCSK9i, showing a 57% reduction in total cholesterol - Pro...